« Back to news listing

Series D Funding Round Yields $24 Million for Ocular Therapeutix

Ocular Therapeutix, a medical device manufacturer based in Bedford, Massachusetts, announced that it had successfully raised $24 million in a Series D financing round. Funds from this latest round will be used to pursue development and commercialization of its ocular drug release technology. In the short-term, funds will be used to back clinical trials of its drug elution system.

Read entire article: http://www.qmed.com/news/series-d-funding-round-yields-24-million-occular-therapeutix?cid=nl_qmed_daily

« Back to news listing